Autori: Mistry Pramod K
| Naslov | Clinical outcomes after 4.5 years of eliglustat therapy for Gaucher disease type 1: Phase 3 ENGAGE trial final results (Article) |
| Autori | Mistry Pramod K ... Petakov Milan S ... (broj koautora 18) |
| Info | AMERICAN JOURNAL OF HEMATOLOGY, (2021), vol. 96 br. 9, str. 1156-1165 |
| Projekat | Sanofi GenzymeSanofi-AventisGenzyme Corporation |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Individual patient responses to eliglustat in treatment-naive adults with Gaucher disease type 1: Final data from the phase 3 ENGAGE trial (Meeting Abstract) |
| Autori | Mistry Pramod K ... Petakov Milan S ... (broj koautora 18) |
| Info | MOLECULAR GENETICS AND METABOLISM, (2020), vol. 129 br. 2, str. S110-S111 |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Addendum to Letter to the Editor: Safety, efficacy, and authorization of eliglustat as a first-line therapy in Gaucher disease type 1 (Letter) |
| Autori | Mistry Pramod K ... Petakov Milan S ... (broj koautora 26) |
| Info | BLOOD CELLS MOLECULES AND DISEASES, (2019), vol. 77 br. , str. 101-102 |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Safety, efficacy, and authorization of eliglustat as a first-line therapy in Gaucher disease type 1 (Letter) |
| Autori | Mistry Pramod K ... Petakov Milan S ... (broj koautora 26) |
| Info | BLOOD CELLS MOLECULES AND DISEASES, (2018), vol. 71 br. , str. 71-74 |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Outcomes after 18 months of eliglustat therapy in treatment-naive adults with Gaucher disease type 1: The phase 3 ENGAGE trial (Article) |
| Autori | Mistry Pramod K ... Petakov Milan S ... (broj koautora 18) |
| Info | AMERICAN JOURNAL OF HEMATOLOGY, (2017), vol. 92 br. 11, str. 1170-1176 |
| Projekat | Sanofi Genzyme |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Long-term results of ENGAGE: a phase 3, randomized, double blind, placebo-controlled, multi center study investigating the efficacy and safety of eliglustat in adults with type 1 Gaucher disease (Meeting Abstract) |
| Autori | Mistry Pramod K ... Petakov Milan S ... (broj koautora 18) |
| Info | MOLECULAR GENETICS AND METABOLISM, (2017), vol. 120 br. 1-2, str. S97-S98 |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Effect of Oral Eliglustat on Splenomegaly in Patients With Gaucher Disease Type 1 The ENGAGE Randomized Clinical Trial (Article) |
| Autori | Mistry Pramod K ... Petakov Milan S ... (broj koautora 21) |
| Info | JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, (2015), vol. 313 br. 7, str. 695-706 |
| Projekat | Genzyme |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | A phase 3, randomized, double-blind, placebo-controlled, multi-center study to investigate the efficacy and safety of eliglustat in patients with Gaucher disease type 1 (ENGAGE): Results after 9 months of treatment (Meeting Abstract) |
| Autori | Mistry Pramod K Lukina Elena Ben Dridi Marie-Francoise Amato Dominick J Baris Hagit Dasouki Majed Ghosn Marwan Mehta Atul Packman Seymour Pastores Gregory M Petakov Milan S Peterschmitt Judith M |
| Info | MOLECULAR GENETICS AND METABOLISM, (2013), vol. 108 br. 2, str. S66-S67 |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
